Merck Swaps Lead Attorney For Vioxx Appeal
Months after the U.S. Supreme Court agreed to hear Merck & Co. Inc.'s appeal of a decision that reinstated a securities class action alleging it concealed the health risks of its...To view the full article, register now.
Already a subscriber? Click here to view full article